[go: up one dir, main page]

BG102817A - Модулатори на tnf рецептор асоцииран фактор (traf), тяхното получаване и употреба - Google Patents

Модулатори на tnf рецептор асоцииран фактор (traf), тяхното получаване и употреба

Info

Publication number
BG102817A
BG102817A BG102817A BG10281798A BG102817A BG 102817 A BG102817 A BG 102817A BG 102817 A BG102817 A BG 102817A BG 10281798 A BG10281798 A BG 10281798A BG 102817 A BG102817 A BG 102817A
Authority
BG
Bulgaria
Prior art keywords
traf
preparation
factor
application
receptor
Prior art date
Application number
BG102817A
Other languages
English (en)
Other versions
BG64755B1 (bg
Inventor
David Wallach
Nikolai Malinin
Mark Boldin
Andrei Kovalenko
Igor Mett
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL11780096A external-priority patent/IL117800A0/xx
Priority claimed from IL11913396A external-priority patent/IL119133A0/xx
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of BG102817A publication Critical patent/BG102817A/bg
Publication of BG64755B1 publication Critical patent/BG64755B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Изобретението се отнася до ДНК последователност, кодираща белтък, способен да се свързва към рецепторасоциирана фактор молекула за туморнекрозисен фактор (TRAF), до ТRAF-свързващи белтъци, техните изоформи, аналози, фрагменти и производни, кодирани от ДНК последователността, а също и до методи за получаване на ДНК-последователностите и белтъците итяхното приложение.
BG102817A 1996-04-02 1998-10-07 Модулатори на tnf рецептор асоцииран фактор (traf), тяхното получаване и употреба BG64755B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11780096A IL117800A0 (en) 1996-04-02 1996-04-02 Modulators of TNF receptor associated factor (TRAF) their preparation and use
IL11913396A IL119133A0 (en) 1996-08-26 1996-08-26 Modulators of TNF receptor associated factor (TRAF) their preparation and use

Publications (2)

Publication Number Publication Date
BG102817A true BG102817A (bg) 1999-05-31
BG64755B1 BG64755B1 (bg) 2006-02-28

Family

ID=26323248

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102817A BG64755B1 (bg) 1996-04-02 1998-10-07 Модулатори на tnf рецептор асоцииран фактор (traf), тяхното получаване и употреба

Country Status (22)

Country Link
US (2) US7485456B1 (bg)
EP (1) EP0894130B1 (bg)
JP (1) JP4180114B2 (bg)
CN (1) CN1197966C (bg)
AT (1) ATE380866T1 (bg)
AU (1) AU732793B2 (bg)
BG (1) BG64755B1 (bg)
BR (1) BR9708518A (bg)
CA (1) CA2250085C (bg)
CZ (3) CZ299682B6 (bg)
DE (1) DE69738370T2 (bg)
DK (1) DK0894130T3 (bg)
EA (1) EA004309B1 (bg)
EE (1) EE04783B1 (bg)
ES (1) ES2294796T3 (bg)
HU (1) HU226328B1 (bg)
NO (1) NO327054B1 (bg)
NZ (1) NZ331902A (bg)
PT (1) PT894130E (bg)
SK (3) SK287085B6 (bg)
UA (1) UA71889C2 (bg)
WO (1) WO1997037016A1 (bg)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
JP2003525567A (ja) * 1997-11-07 2003-09-02 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー 分泌蛋白およびそれらをコードするポリヌクレオチド
US6265538B1 (en) * 1998-02-27 2001-07-24 The Regents Of The University Of California Inhibitor of the inflammatory response induced by the TNFA and IL-1
DE69928244T2 (de) * 1998-05-06 2006-08-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Inhibitoren der nf-kb aktivierung
TR200100624T2 (tr) * 1998-08-18 2001-08-21 Aktiengesellschaft Basf TPL-2/Cot kinaz ve kullanım yöntemleri.
IL131719A0 (en) * 1999-09-02 2001-03-19 Yeda Res & Dev Iren protein its preparation and use
GB9930616D0 (en) * 1999-12-24 2000-02-16 Mathilda & Terence Kennedy Ins Activation and inhibition of the immune system
US20040109854A1 (en) * 2001-02-21 2004-06-10 Zang-Hee Lee Novel traf6 inhibiting protein
AU2002350412B2 (en) 2001-06-22 2006-06-15 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Abin-mediated hepatitis protection
EP1499729B9 (en) * 2002-04-18 2012-03-14 Yeda Research And Development Co., Ltd. Derivatives of the nf-kappab inducing enzyme, their preparation and use
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
WO2005033145A1 (en) * 2003-10-07 2005-04-14 Yeda Research And Development Co. Ltd. Antibodies to nik, their preparation and use
CA2547459C (en) * 2003-11-30 2013-10-08 Yeda Research And Development Co. Ltd Modulators of nik-siva complex formation for treating immune disorders
IL173104A0 (en) * 2006-01-12 2006-06-11 Yeda Res & Dev Siva and ubiquintination
ES2752025T3 (es) 2008-07-25 2020-04-02 Wagner Richard W Métodos de cribado de proteínas
GB201012420D0 (en) 2010-07-23 2010-09-08 Univ Erasmus Medical Ct Foetal heamoglobin inhibitor
CA2808539C (en) 2010-08-25 2021-05-25 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases
CN105177032B (zh) * 2010-09-01 2019-05-10 山东新时代药业有限公司 新型人肿瘤坏死因子受体-Fc融合基因及其产物蛋白
WO2012123522A1 (en) 2011-03-16 2012-09-20 F. Hoffmann-La Roche Ag 6,5-heterocyclic propargylic alcohol compounds and uses therefor
ES2810424T3 (es) 2011-06-30 2021-03-08 Genzyme Corp Inhibidores de la activación de células T
EP2734232B1 (en) 2011-07-19 2017-11-01 Philogen S.p.A. Sequential anti-ctla4 and targeted il-2 therapy
UY34317A (es) 2011-09-12 2013-02-28 Genzyme Corp Anticuerpo antireceptor de célula T (alfa)/ß
CA2974651A1 (en) 2014-01-24 2015-07-30 Children's Hospital Of Eastern Ontario Research Institute Inc. Smc combination therapy for the treatment of cancer
CN105986001B (zh) * 2015-02-12 2019-12-03 上海交通大学 一种基于膜结合蛋白和荧光互补的高通量猎物拮抗剂筛选方法
EP3313887A2 (en) 2015-06-26 2018-05-02 MAB Discovery GmbH Monoclonal anti-il-1racp antibodies
WO2020206063A1 (en) 2019-04-03 2020-10-08 Genzyme Corporation Anti-alpha beta tcr binding polypeptides with reduced fragmentation
TW202428613A (zh) 2022-09-21 2024-07-16 法商賽諾菲生物技術公司 人源化抗il-1r3抗體及使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641876A (en) * 1990-01-05 1997-06-24 Cornell Research Foundation, Inc. Rice actin gene and promoter
EP0841934A1 (en) * 1995-08-02 1998-05-20 Teresa J. Ingram Composition for administration to patients with chronic fatigue syndrome and acquired immune deficiency syndrome
AU6692996A (en) * 1995-08-08 1997-03-05 Tularik Inc. Inhibitors of apoptosis
US5804412A (en) * 1996-04-01 1998-09-08 The Regents Of The University Of California Nucleic acids encoding sorting nexins and methods of using same
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування
EP0904346A4 (en) 1996-05-08 2000-11-29 Henkel Corp ALKYL POLYGLYCOSIDE ETHER CARBOXYLATES
US5843721A (en) * 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein

Also Published As

Publication number Publication date
JP4180114B2 (ja) 2008-11-12
UA71889C2 (uk) 2005-01-17
EE9800322A (et) 1999-04-15
CN1221449A (zh) 1999-06-30
EP0894130A1 (en) 1999-02-03
SK287890B6 (sk) 2012-03-02
CZ299682B6 (cs) 2008-10-15
DE69738370D1 (de) 2008-01-24
US20090291888A1 (en) 2009-11-26
EA004309B1 (ru) 2004-02-26
BR9708518A (pt) 1999-08-03
EP0894130B1 (en) 2007-12-12
NZ331902A (en) 2000-02-28
SK136198A3 (en) 1999-05-07
JP2000507826A (ja) 2000-06-27
WO1997037016A1 (en) 1997-10-09
SK287085B6 (sk) 2009-11-05
EE04783B1 (et) 2007-02-15
AU2175597A (en) 1997-10-22
SK287889B6 (sk) 2012-03-02
CN1197966C (zh) 2005-04-20
ES2294796T3 (es) 2008-04-01
CA2250085A1 (en) 1997-10-09
CA2250085C (en) 2009-10-20
HUP9902429A2 (hu) 1999-10-28
US7485456B1 (en) 2009-02-03
DK0894130T3 (da) 2008-01-07
CZ298866B6 (cs) 2008-02-27
CZ299094B6 (cs) 2008-04-23
NO984551D0 (no) 1998-09-29
NO984551L (no) 1998-11-24
US8236507B2 (en) 2012-08-07
ATE380866T1 (de) 2007-12-15
NO327054B1 (no) 2009-04-14
AU732793B2 (en) 2001-05-03
DE69738370T2 (de) 2008-12-04
HK1018910A1 (en) 2000-01-07
CZ318398A3 (cs) 1999-05-12
EA199800885A1 (ru) 1999-04-29
HU226328B1 (en) 2008-09-29
PT894130E (pt) 2008-01-14
BG64755B1 (bg) 2006-02-28
HUP9902429A3 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
BG102817A (bg) Модулатори на tnf рецептор асоцииран фактор (traf), тяхното получаване и употреба
IL193919A0 (en) DcR3 POLYPEPTIDE A TNFR HOMOLOG
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
IL193886A (en) Antibodies that bind to ldcam sequences
WO2000001815A3 (en) Neurotrophic factors
HUT75825A (en) Protocadherin proteins and their uses
CA2200423A1 (en) Novel estrogen receptor
EP0769554A3 (en) Human CNP gene and precursor protein
AU3346289A (en) Heparin-binding proteins, DNA coding for them, processes for producing them as well as therapeutic preparations containing them
MY125980A (en) Highly purified cytokine activating factor and methods of use
FI863626A7 (fi) DNA-sekvenssejä, yhdistelmä-DNA -molekyylejä ja menetelmiä ihmisen lip okortiinin kaltaisia polypeptidejä.
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
AU3711597A (en) A novel galanin receptor
AU4375493A (en) Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof
IL129139A0 (en) Vertebrate smoothened proteins
NZ294019A (en) Proteins associated with the hippocampus; dna sequences coding therefor, antibodies to the proteins
WO2000024771A3 (en) Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
WO1998024896A3 (en) Muteins of obese protein
WO1990003394A3 (fr) Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
ZA903843B (en) Tumor necrosis factor binding protein ii,its purification and antibodies thereto
DE69939587D1 (en) Semaphorin polypeptide
EP1019500A4 (en) NEW IFN RECEPTOR 1 BINDING PROTEINS, ENCODING DNA AND METHOD FOR REGULATING THE CELLULAR RESPONSE TO INTERFERON
WO2000037634A3 (en) Novel polypeptides and nucleic acids encoding same